Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Imaging BiometricsIQAIF PB Ratio is 10.00 as of Jul. 18, 2026, which is 44% above its 10-year median of 6.94. The stock has 3 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Imaging Biometrics ranks worse than 67.54% on this metric.
The historical rank and industry rank for Imaging Biometrics's PB Ratio or its related term are showing as below:
IQAIF'
s PB Ratio Range Over the Past 10 Years
Min: 1.71 Med: 6.94 Max: 19.38
Current: 3
During the past 13 years, Imaging Biometrics's highest PB Ratio was 19.38. The lowest was 1.71. And the median was 6.94.
IQAIF's PB Ratio is ranked worse than 67.54% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.025
vs IQAIF: 3.00
During the past 12 months, Imaging Biometrics's average Book Value Per Share Growth Rate was 100.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -20.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Imaging Biometrics was 136.40% per year. The lowest was -75.00% per year. And the median was -7.30% per year.
Back to Basics: PB Ratio
Imaging Biometrics (OTCPK:IQAIF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Imaging Biometrics PB Ratio Related Terms
Imaging Biometrics PB Ratio Historical Data
* Premium members only.
The historical data trend for Imaging Biometrics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Imaging Biometrics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imaging Biometrics PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Imaging Biometrics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Imaging Biometrics (IQAIF) has a PB Ratio of 10.00 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Imaging Biometrics and its competitors. This is 44% above median its historical median of 6.94. Over the past decade, Imaging Biometrics' PB Ratio has ranged from 1.71 to 19.38. According to the industry distribution chart, Imaging Biometrics ranks #412 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 67.5%.
Is Imaging Biometrics' PB Ratio too high?
Imaging Biometrics' current PB Ratio of 10.00 is 44% above median its 10-year median of 6.94. Over the past 10 years, this metric has ranged from a low of 1.71 to a high of 19.38. The Healthcare Providers & Services industry median PB Ratio is 2.03. Imaging Biometrics' value of 10.00 is 393.8% above this industry median. Based on the distribution chart, Imaging Biometrics ranks #412 out of 610 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Imaging Biometrics' PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #412 out of 610 companies for PB Ratio. This places Imaging Biometrics in the lower half of its industry. The industry median PB Ratio is 2.03. Imaging Biometrics' value of 10.00 is 393.8% above this benchmark. Historically, Imaging Biometrics' own PB Ratio has ranged from 1.71 to 19.38 over the past decade. While the company's 10-year median is 6.94 vs. the industry median of 2.03, Imaging Biometrics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.03, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imaging Biometrics's current PB Ratio of 10.00 is 393.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current PB Ratio is 10.00, which is 44% above median its own 10-year median of 6.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current PB Ratio of 10.00. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current PB Ratio is 10.00, which is 44% above median its 10-year median of 6.94 and 393.8% above the Healthcare Providers & Services industry median of 2.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current PB Ratio is 10.00 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IQAIF has been successfully added to your 
